RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Clinical Trials
  Myocardial Infarction
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
CAD Channel

subscribe to CAD newsletter
Latest Research : Cardiology : CAD

   EMAIL   |   PRINT
Delayed enhancement cardiovascular magnetic resonance to detect non-Q wave heart attacks

Apr 25, 2009 - 3:10:08 PM , Reviewed by: Dr. Sanjukta Acharya

[RxPG] In a paper published by PLoS Medicine, Han W. Kim and colleagues from the Duke Cardiovascular Magnetic Resonance Center, United States of America, use a recently developed technique to detect heart damage in patients who don't have symptoms or abnormalities in the electrocardiogram (ECG) that are usually associated with a heart attack ( myocardial infarction ). They show that the prevalence of this type of heart attack which doesn't display ECG abnormalities is more than three times higher than heart damage which does display ECG abnormalities.

Although coronary artery disease is the leading cause of death among adults in developed countries, up to 40 60% of heart attacks are not preceded by typical symptoms and are not immediately identified by patients or physicians, if at all. Therefore, these heart attacks are known as unrecognized myocardial infarctions (UMIs). The diagnosis of UMI is currently based on the appearance of changes in the ECG, leading to so-called Q-waves . However, not all UMIs result in Q-waves. Han Kim and colleagues therefore used a technique known as delayed enhancement cardiovascular magnetic resonance (DE-CMR) to detect heart damage in patients whose Q-waves were absent.

The researchers studied 185 patients with suspected coronary artery disease but with no history of heart attacks. They then followed the patients for 2 years to discover whether a diagnosis of non-Q-wave UMI predicted their likelihood of dying from any cause including from a heart problem. They found that non-Q-wave UMI occurred more than three times as often in patients with suspected coronary artery disease than Q-wave UMI. They also found that patients with this silent heart damage had an 11-fold higher risk of death from any cause and a 17-fold higher risk of death from a heart problem than patients without heart damage.

The clinical implications of the study are discussed in an expert commentary by Clara Kayei Chow from the Population Health Research Institute, McMaster University, Canada, and The George Institute for International Health, University of Sydney, Australia, who was not involved in the study. This important new study has two key clinical implications. First, previous non-Q-wave UMI is potentially being missed in patients with suspected coronary artery disease. Second, non-Q-wave UMI is important because it is significantly associated with increased mortality, she says. She also points out, however, that the results are from a small select group of patients and that further studies need to be done to evaluate the determinants of the increased mortality in patients with non-Q wave UMI. In addition the study will need repeating in other groups of patients. Finally, two of the authors are named on a US patent on the technique used in this study, Delayed Enhancement CMR. The patent itself is owned by Northwestern University.

Publication: Open access journal, PLoS Medicine

Advertise in this space for $10 per month. Contact us today.

Related CAD News
Pericytes from human leg veins may help with recovery after a myocardial infarction
No difference in graft patency between radial and saphenous vein grafts in CABG procedures
Nanoparticles - possible alternative to drug eluting stents
Heart stem/progenitor cells improve mouse heart function after a heart attack
Delayed enhancement cardiovascular magnetic resonance to detect non-Q wave heart attacks
Post-arrest survival better in high volume hospitals
New European guidelines on the management of ST segment elevation myocardial infarction
Bivalirudin during primary angioplasty better than heparin and glycoprotein IIb/IIIa inhibitors (GPI).
Intermittent hypoxic treatment for reduced myocardial infarction and lethal arrhythmias
MDCT accurate in detecting stenosis in calcified coronary artery plaque

Subscribe to CAD Newsletter

Enter your email address:

 About Dr. Sanjukta Acharya
This news story has been reviewed by Dr. Sanjukta Acharya before its publication on RxPG News website. Dr. Sanjukta Acharya, MBBS MRCP is the chief editor for RxPG News website. She oversees all the medical news submissions and manages the medicine section of the website. She has a special interest in nephrology. She can be reached for corrections and feedback at [email protected]
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)